<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://raw.githubusercontent.com/cease353/xtest/master/current/spl_canada.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="urn:hl7-org:v3 https://raw.githubusercontent.com/HealthCanada/HPFB/master/Structured-Product-Labeling-(SPL)/Schema/current/SPL.xsd">
  <templateId extension="NDS" root="2.16.840.1.113883.2.20.6.37"/>
  <id root="aeb4ec67-8764-4b72-b7a5-0bae88db11a3"/>
  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.10"
    displayName="2016 PRODUCT MONOGRAPH TEMPLATE - STANDARD"/>
  <title>Twynsta (Telmisartan / Amlodipine (as Amlodipine Besylate)) Tablets</title>
  <effectiveTime value="20170101">
    <!-- Date of Last Revision -->
    <originalText description="Date of Initial Approval">20190807</originalText>
  </effectiveTime>
  <languageCode code="1" codeSystem="2.16.840.1.113883.2.20.6.29" displayName="ENGLISH"/>
  <setId root="dd76ec67-9064-4b72-b7a5-0bae88db11a3"/>
  <versionNumber value="1"/>
  <author>
    <!--Organization Information-->
    <time/>
    <assignedEntity>
      <representedOrganization>
        <!--Market Authorization Holder-->
        <id extension="3617" root="2.16.840.1.113883.2.20.6.31"/>
        <name>BOEHRINGER INGELHEIM (CANADA) LTD LTEE</name>
        <contactParty>
          <addr>
            <streetAddressLine>5180 South Service Road</streetAddressLine>
            <city>Burlington</city>
            <state>Ontario</state>
            <postalCode>L7L 5H4</postalCode>
            <country code="CAN" codeSystem="2.16.840.1.113883.2.20.6.17" displayName="CANADA"/>
          </addr>
          <telecom value="tel:+18002635103"/>
          <telecom value="mailto:test@boehringer.ca"/>
          <telecom value="https://www.boehringer-ingelheim.ca"/>
          <contactPerson/>
          <!-- How to capture without contactPerson?-->
        </contactParty>
      </representedOrganization>
    </assignedEntity>
  </author>
  <component>
    <structuredBody>
      <component>
        <!-- Manufactured Product Information -->
        <section ID="f6ac9de5-be91-442c-9579-5bc9ebd36902">
          <id root="bdeefc11-4315-41e3-8c56-83e8bf4f770b"/>
          <code code="MP" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="MANUFACTURED PRODUCT"/>
		  <title>MANUFACTURED PRODUCT</title>
          <effectiveTime value="20170101"/>
          <subject>
            <manufacturedProduct>
              <manufacturedProduct>
                <code code="02371022" codeSystem="2.16.840.1.113883.2.20.6.42"/>
                <!-- DIN Number -->
                <name>Twynsta</name>
                <formCode code="10219000" codeSystem="2.16.840.1.113883.2.20.6.3" displayName="TABLET"/>
                <asEntityWithGeneric>
                  <genericMedicine>
                    <name>telmisartan/amlodipine</name>
                  </genericMedicine>
                </asEntityWithGeneric>
                <ingredient classCode="ACTIB">
                  <quantity>
                    <numerator value="40" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="TELMISARTAN"/>
                    <name>TELMISARTAN</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="TELMISARTAN"/>
                        <name>TELMISARTAN</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="ACTIM">
                  <quantity>
                    <numerator value="5" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="1223" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="AMLODIPINE BESYLATE"/>
                    <name>AMLODIPINE BESYLATE</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11344" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="AMLODIPINE"/>
                        <name>AMLODIPINE</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="colloidal anhydrous silica"/>
                    <name>colloidal anhydrous silica</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="FD&amp;C blue No 1"/>
                    <name>FD&amp;C blue No 1</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="aluminium lake (E 133)"/>
                    <name>aluminium lake (E 133)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="erric oxide black (E172)"/>
                    <name>erric oxide black (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="ferric oxide yellow (E172)"/>
                    <name>ferric oxide yellow (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="magnesium stearate"/>
                    <name>magnesium stearate</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="maize starch"/>
                    <name>maize starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14" displayName="meglumine"/>
                    <name>meglumine</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="microcrystalline cellulose"/>
                    <name>microcrystalline cellulose</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="povidone K25"/>
                    <name>povidone K25</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="pregelatinized starch"/>
                    <name>pregelatinized starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sodium hydroxide"/>
                    <name>sodium hydroxide</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sorbitol (E420)"/>
                    <name>sorbitol (E420)</name>
                  </ingredientSubstance>
                </ingredient>
                <asContent>
                  <!-- Packaging -->
                  <quantity>
                    <numerator value="7" unit="1"/>
                    <denominator value="1"/>
                  </quantity>
                  <containerPackagedProduct>
                    <code code="1234"/>
                    <!--company defined pack code-->
                    <formCode code="30007000" codeSystem="2.16.840.1.113883.2.20.6.32"
                      displayName="BLISTER"/>
                    <asContent>
                      <quantity>
                        <numerator value="4" unit="1"/>
                        <denominator value="1"/>
                      </quantity>
                      <containerPackagedProduct>
                        <code code="4567"/>
                        <!--company defined pack code-->
                        <formCode code="30009000" codeSystem="2.16.840.1.113883.2.20.6.32"
                          displayName="BOX"/>
                      </containerPackagedProduct>
                      <subjectOf>
                        <marketingAct>
                          <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                          <!-- regulatory status of this package -->
                          <statusCode code="ACTIVE"/>
                          <effectiveTime>
                            <low value="20190807"/>
                            <!-- Date of initial approval -->
                          </effectiveTime>
                        </marketingAct>
                      </subjectOf>					  
                    </asContent>
                  </containerPackagedProduct>
                </asContent>
              </manufacturedProduct>
              <subjectOf>
                <!--Regulatory Activity associated with this products status-->
                <approval>
                  <id extension="225785" root="2.16.840.1.113883.2.20.6.49"/>
                  <!-- Control Number -->
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.37" displayName="NDS"/>
                  <author>
                    <territorialAuthority>
                      <territory>
                        <code code="CAN" codeSystem="2.16.840.1.113883.2.20.6.17"
                          displayName="CANADA"/>
                      </territory>
                    </territorialAuthority>
                  </author>
                </approval>
              </subjectOf>
              <subjectOf>
                <!--Regulatory status of this product-->
                <marketingAct>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                  <statusCode code="ACTIVE"/>
                  <effectiveTime>
                    <low value="20190807"/>
                    <!-- Date of initial approval. Include high value=yyyymmdd if cancelled -->
                  </effectiveTime>
                </marketingAct>
              </subjectOf>
              <!--Characteristics of this product-->
              <subjectOf>
                <characteristic>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="PRODUCT TYPE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.53"
                    displayName="PHARMACEUTICAL" xsi:type="CV">
                    <originalText>PHARMACEUTICAL</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="WHITE"
                    xsi:type="CV">
                    <originalText>white to off-white</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="2" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="BLUE"
                    xsi:type="CV">
                    <originalText>Blue</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="3" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SHAPE"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.25" displayName="OVAL"
                    xsi:type="CV">
                    <originalText>Oval</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="4" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SIZE"/>
                  <value xsi:type="PQ" value="14" unit="mm"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="5" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SCORE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.4" displayName="1"
				  xsi:type="CV">
				  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="6" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="IMPRINT"/>
                  <value xsi:type="ST">A1</value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="8" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="COMBINATION PRODUCT"/>
                  <value code="xx" codeSystem="2.16.840.1.113883.2.20.6.8" xsi:type="CV"
                    displayName="NOT A COMBINATION PRODUCT"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="9" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="PHARMACEUTICAL STANDARD"/>
                  <value code="4" codeSystem="2.16.840.1.113883.2.20.6.5" displayName="MFR"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="10" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="SCHEDULE"/>
                  <value code="6" codeSystem="2.16.840.1.113883.2.20.6.2" displayName="PRESCRIPTION"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="96447" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="ANGIOTENSIN II RECEPTOR ANTAGONISTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="61287" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <consumedIn>
                <substanceAdministration>
                  <routeCode code="20053000" codeSystem="2.16.840.1.113883.2.20.6.7" displayName="ORAL USE"/>
                </substanceAdministration>
              </consumedIn>
            </manufacturedProduct>
          </subject>
          <subject>
            <manufacturedProduct>
              <manufacturedProduct>
                <code code="02371030" codeSystem="2.16.840.1.113883.2.20.6.42"/>
                <!-- DIN Number -->
                <name>Twynsta</name>
                <formCode code="10219000" codeSystem="2.16.840.1.113883.2.20.6.3" displayName="TABLET"/>
                <asEntityWithGeneric>
                  <genericMedicine>
                    <name>telmisartan/amlodipine</name>
                  </genericMedicine>
                </asEntityWithGeneric>
                <ingredient classCode="ACTIB">
                  <quantity>
                    <numerator value="40" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="TELMISARTAN"/>
                    <name>TELMISARTAN</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="TELMISARTAN"/>
                        <name>TELMISARTAN</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="ACTIM">
                  <quantity>
                    <numerator value="10" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="1223" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="AMLODIPINE BESYLATE"/>
                    <name>AMLODIPINE BESYLATE</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11344" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="AMLODIPINE"/>
                        <name>AMLODIPINE</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="colloidal anhydrous silica"/>
                    <name>colloidal anhydrous silica</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="FD&amp;C blue No 1"/>
                    <name>FD&amp;C blue No 1</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="aluminium lake (E 133)"/>
                    <name>aluminium lake (E 133)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="erric oxide black (E172)"/>
                    <name>erric oxide black (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="ferric oxide yellow (E172)"/>
                    <name>ferric oxide yellow (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="magnesium stearate"/>
                    <name>magnesium stearate</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="maize starch"/>
                    <name>maize starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14" displayName="meglumine"/>
                    <name>meglumine</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="microcrystalline cellulose"/>
                    <name>microcrystalline cellulose</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="povidone K25"/>
                    <name>povidone K25</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="pregelatinized starch"/>
                    <name>pregelatinized starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sodium hydroxide"/>
                    <name>sodium hydroxide</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sorbitol (E420)"/>
                    <name>sorbitol (E420)</name>
                  </ingredientSubstance>
                </ingredient>
                <asContent>
                  <!-- Packaging -->
                  <quantity>
                    <numerator value="7" unit="1"/>
                    <denominator value="1"/>
                  </quantity>
                  <containerPackagedProduct>
                    <code code="2"/>
                    <!--company defined pack code-->
                    <formCode code="30007000" codeSystem="2.16.840.1.113883.2.20.6.32"
                      displayName="BLISTER"/>
                    <asContent>
                      <quantity>
                        <numerator value="4" unit="1"/>
                        <denominator value="1"/>
                      </quantity>
                      <containerPackagedProduct>
                        <code code="4567"/>
                        <!--company defined pack code-->
                        <formCode code="30009000" codeSystem="2.16.840.1.113883.2.20.6.32"
                          displayName="BOX"/>
                      </containerPackagedProduct>
	                  <subjectOf>
                         <marketingAct>
                         <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                         <!-- regulatory status of this package -->
                         <statusCode code="ACTIVE"/>
                            <effectiveTime>
                               <low value="20190807"/>
                               <!-- Date of initial approval -->
                            </effectiveTime>
                         </marketingAct>
                      </subjectOf>				  
                    </asContent>
                  </containerPackagedProduct>
                </asContent>
              </manufacturedProduct>
              <subjectOf>
                <!--Regulatory Activity associated with this products status-->
                <approval>
                  <id extension="225785" root="2.16.840.1.113883.2.20.6.49"/>
                  <!-- Control Number -->
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.37" displayName="NDS"/>
                  <author>
                    <territorialAuthority>
                      <territory>
                        <code code="CAN" codeSystem="2.16.840.1.113883.2.20.6.17"
                          displayName="CANADA"/>
                      </territory>
                    </territorialAuthority>
                  </author>
                </approval>
              </subjectOf>
              <subjectOf>
                <!--Regulatory status of this product-->
                <marketingAct>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                  <statusCode code="ACTIVE"/>
                  <effectiveTime>
                    <low value="20190807"/>
                    <!-- Date of initial approval. Include high value=yyyymmdd if cancelled -->
                  </effectiveTime>
                </marketingAct>
              </subjectOf>
              <!--Characteristics of this product-->
              <subjectOf>
                <characteristic>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="PRODUCT TYPE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.53"
                    displayName="PHARMACEUTICAL" xsi:type="CV">
                    <originalText>PHARMACEUTICAL</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="WHITE"
                    xsi:type="CV">
                    <originalText>white to off-white</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="2" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="BLUE"
                    xsi:type="CV">
                    <originalText>Blue</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="3" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SHAPE"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.25" displayName="OVAL"
                    xsi:type="CV">
                    <originalText>Oval</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="4" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SIZE"/>
                  <value xsi:type="PQ" value="14" unit="mm"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="5" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SCORE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.4" displayName="1"
				  xsi:type="CV">
				  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="6" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="IMPRINT"/>
                  <value xsi:type="ST">A2</value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="8" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="COMBINATION PRODUCT"/>
                  <value code="xx" codeSystem="2.16.840.1.113883.2.20.6.8" xsi:type="CV"
                    displayName="NOT A COMBINATION PRODUCT"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="9" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="PHARMACEUTICAL STANDARD"/>
                  <value code="4" codeSystem="2.16.840.1.113883.2.20.6.5" displayName="MFR"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="10" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="SCHEDULE"/>
                  <value code="6" codeSystem="2.16.840.1.113883.2.20.6.2" displayName="PRESCRIPTION"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="96447" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="ANGIOTENSIN II RECEPTOR ANTAGONISTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="61287" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <consumedIn>
                <substanceAdministration>
                  <routeCode code="20053000" codeSystem="2.16.840.1.113883.2.20.6.7" displayName="ORAL USE"/>
                </substanceAdministration>
              </consumedIn>
            </manufacturedProduct>
          </subject>
          <subject>
            <manufacturedProduct>
              <manufacturedProduct>
                <code code="02371049" codeSystem="2.16.840.1.113883.2.20.6.42"/>
                <!-- DIN Number -->
                <name>Twynsta</name>
                <formCode code="10219000" codeSystem="2.16.840.1.113883.2.20.6.3" displayName="TABLET"/>
                <asEntityWithGeneric>
                  <genericMedicine>
                    <name>telmisartan/amlodipine</name>
                  </genericMedicine>
                </asEntityWithGeneric>
                <ingredient classCode="ACTIB">
                  <quantity>
                    <numerator value="80" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="TELMISARTAN"/>
                    <name>TELMISARTAN</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="TELMISARTAN"/>
                        <name>TELMISARTAN</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="ACTIM">
                  <quantity>
                    <numerator value="5" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="1223" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="AMLODIPINE BESYLATE"/>
                    <name>AMLODIPINE BESYLATE</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11344" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="AMLODIPINE"/>
                        <name>AMLODIPINE</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="colloidal anhydrous silica"/>
                    <name>colloidal anhydrous silica</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="FD&amp;C blue No 1"/>
                    <name>FD&amp;C blue No 1</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="aluminium lake (E 133)"/>
                    <name>aluminium lake (E 133)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="erric oxide black (E172)"/>
                    <name>erric oxide black (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="ferric oxide yellow (E172)"/>
                    <name>ferric oxide yellow (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="magnesium stearate"/>
                    <name>magnesium stearate</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="maize starch"/>
                    <name>maize starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14" displayName="meglumine"/>
                    <name>meglumine</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="microcrystalline cellulose"/>
                    <name>microcrystalline cellulose</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="povidone K25"/>
                    <name>povidone K25</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="pregelatinized starch"/>
                    <name>pregelatinized starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sodium hydroxide"/>
                    <name>sodium hydroxide</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sorbitol (E420)"/>
                    <name>sorbitol (E420)</name>
                  </ingredientSubstance>
                </ingredient>
                <asContent>
                  <!-- Packaging -->
                  <quantity>
                    <numerator value="7" unit="1"/>
                    <denominator value="1"/>
                  </quantity>
                  <containerPackagedProduct>
                    <code code="3"/>
                    <!--company defined pack code-->
                    <formCode code="30007000" codeSystem="2.16.840.1.113883.2.20.6.32"
                      displayName="BLISTER"/>
                    <asContent>
                      <quantity>
                        <numerator value="4" unit="1"/>
                        <denominator value="1"/>
                      </quantity>
                      <containerPackagedProduct>
                        <code code="4567"/>
                        <!--company defined pack code-->
                        <formCode code="30009000" codeSystem="2.16.840.1.113883.2.20.6.32"
                          displayName="BOX"/>
                      </containerPackagedProduct>
	                  <subjectOf>
                         <marketingAct>
                         <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                         <!-- regulatory status of this package -->
                         <statusCode code="ACTIVE"/>
                            <effectiveTime>
                               <low value="20190807"/>
                               <!-- Date of initial approval -->
                            </effectiveTime>
                         </marketingAct>
                      </subjectOf>				  
                    </asContent>
                  </containerPackagedProduct>
                </asContent>
              </manufacturedProduct>
              <subjectOf>
                <!--Regulatory Activity associated with this products status-->
                <approval>
                  <id extension="225785" root="2.16.840.1.113883.2.20.6.49"/>
                  <!-- Control Number -->
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.37" displayName="NDS"/>
                  <author>
                    <territorialAuthority>
                      <territory>
                        <code code="CAN" codeSystem="2.16.840.1.113883.2.20.6.17"
                          displayName="CANADA"/>
                      </territory>
                    </territorialAuthority>
                  </author>
                </approval>
              </subjectOf>
              <subjectOf>
                <!--Regulatory status of this product-->
                <marketingAct>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                  <statusCode code="ACTIVE"/>
                  <effectiveTime>
                    <low value="20190807"/>
                    <!-- Date of initial approval. Include high value=yyyymmdd if cancelled -->
                  </effectiveTime>
                </marketingAct>
              </subjectOf>
              <!--Characteristics of this product-->
              <subjectOf>
                <characteristic>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="PRODUCT TYPE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.53"
                    displayName="PHARMACEUTICAL" xsi:type="CV">
                    <originalText>PHARMACEUTICAL</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="WHITE"
                    xsi:type="CV">
                    <originalText>white to off-white</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="2" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="BLUE"
                    xsi:type="CV">
                    <originalText>Blue</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="3" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SHAPE"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.25" displayName="OVAL"
                    xsi:type="CV">
                    <originalText>Oval</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="4" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SIZE"/>
                  <value xsi:type="PQ" value="14" unit="mm"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="5" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SCORE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.4" displayName="1"
				  xsi:type="CV">
				  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="6" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="IMPRINT"/>
                  <value xsi:type="ST">A3</value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="8" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="COMBINATION PRODUCT"/>
                  <value code="xx" codeSystem="2.16.840.1.113883.2.20.6.8" xsi:type="CV"
                    displayName="NOT A COMBINATION PRODUCT"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="9" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="PHARMACEUTICAL STANDARD"/>
                  <value code="4" codeSystem="2.16.840.1.113883.2.20.6.5" displayName="MFR"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="10" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="SCHEDULE"/>
                  <value code="6" codeSystem="2.16.840.1.113883.2.20.6.2" displayName="PRESCRIPTION"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="96447" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="ANGIOTENSIN II RECEPTOR ANTAGONISTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="61287" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <consumedIn>
                <substanceAdministration>
                  <routeCode code="20053000" codeSystem="2.16.840.1.113883.2.20.6.7" displayName="ORAL USE"/>
                </substanceAdministration>
              </consumedIn>
            </manufacturedProduct>
          </subject>
          <subject>
            <manufacturedProduct>
              <manufacturedProduct>
                <code code="02371057" codeSystem="2.16.840.1.113883.2.20.6.42"/>
                <!-- DIN Number -->
                <name>Twynsta</name>
                <formCode code="10219000" codeSystem="2.16.840.1.113883.2.20.6.3" displayName="TABLET"/>
                <asEntityWithGeneric>
                  <genericMedicine>
                    <name>telmisartan/amlodipine</name>
                  </genericMedicine>
                </asEntityWithGeneric>
                <ingredient classCode="ACTIB">
                  <quantity>
                    <numerator value="80" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="TELMISARTAN"/>
                    <name>TELMISARTAN</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11907" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="TELMISARTAN"/>
                        <name>TELMISARTAN</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="ACTIM">
                  <quantity>
                    <numerator value="10" unit="mg"/>
                    <denominator value="1" unit="1"/>
                  </quantity>
                  <ingredientSubstance>
                    <code code="1223" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="AMLODIPINE BESYLATE"/>
                    <name>AMLODIPINE BESYLATE</name>
                    <activeMoiety>
                      <activeMoiety>
                        <code code="11344" codeSystem="2.16.840.1.113883.2.20.6.14"
                          displayName="AMLODIPINE"/>
                        <name>AMLODIPINE</name>
                      </activeMoiety>
                    </activeMoiety>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="colloidal anhydrous silica"/>
                    <name>colloidal anhydrous silica</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="FD&amp;C blue No 1"/>
                    <name>FD&amp;C blue No 1</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="aluminium lake (E 133)"/>
                    <name>aluminium lake (E 133)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="erric oxide black (E172)"/>
                    <name>erric oxide black (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="ferric oxide yellow (E172)"/>
                    <name>ferric oxide yellow (E172)</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="magnesium stearate"/>
                    <name>magnesium stearate</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="maize starch"/>
                    <name>maize starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14" displayName="meglumine"/>
                    <name>meglumine</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="microcrystalline cellulose"/>
                    <name>microcrystalline cellulose</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="povidone K25"/>
                    <name>povidone K25</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="pregelatinized starch"/>
                    <name>pregelatinized starch</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sodium hydroxide"/>
                    <name>sodium hydroxide</name>
                  </ingredientSubstance>
                </ingredient>
                <ingredient classCode="IACT">
                  <ingredientSubstance>
                    <code code="xx" codeSystem="2.16.840.1.113883.2.20.6.14"
                      displayName="sorbitol (E420)"/>
                    <name>sorbitol (E420)</name>
                  </ingredientSubstance>
                </ingredient>
                <asContent>
                  <!-- Packaging -->
                  <quantity>
                    <numerator value="7" unit="1"/>
                    <denominator value="1"/>
                  </quantity>
                  <containerPackagedProduct>
                    <code code="4"/>
                    <!--company defined pack code-->
                    <formCode code="30007000" codeSystem="2.16.840.1.113883.2.20.6.32"
                      displayName="BLISTER"/>
                    <asContent>
                      <quantity>
                        <numerator value="4" unit="1"/>
                        <denominator value="1"/>
                      </quantity>
                      <containerPackagedProduct>
                        <code code="4567"/>
                        <!--company defined pack code-->
                        <formCode code="30009000" codeSystem="2.16.840.1.113883.2.20.6.32"
                          displayName="BOX"/>
                      </containerPackagedProduct>
	                  <subjectOf>
                         <marketingAct>
                         <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                         <!-- regulatory status of this package -->
                         <statusCode code="ACTIVE"/>
                            <effectiveTime>
                               <low value="20190807"/>
                               <!-- Date of initial approval -->
                            </effectiveTime>
                         </marketingAct>
                      </subjectOf>				  
                    </asContent>
                  </containerPackagedProduct>
                </asContent>
              </manufacturedProduct>
              <subjectOf>
                <!--Regulatory Activity associated with this products status-->
                <approval>
                  <id extension="225785" root="2.16.840.1.113883.2.20.6.49"/>
                  <!-- Control Number -->
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.37" displayName="NDS"/>
                  <author>
                    <territorialAuthority>
                      <territory>
                        <code code="CAN" codeSystem="2.16.840.1.113883.2.20.6.17"
                          displayName="CANADA"/>
                      </territory>
                    </territorialAuthority>
                  </author>
                </approval>
              </subjectOf>
              <subjectOf>
                <!--Regulatory status of this product-->
                <marketingAct>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.11" displayName="APPROVED"/>
                  <statusCode code="ACTIVE"/>
                  <effectiveTime>
                    <low value="20190807"/>
                    <!-- Date of initial approval. Include high value=yyyymmdd if cancelled -->
                  </effectiveTime>
                </marketingAct>
              </subjectOf>
              <!--Characteristics of this product-->
              <subjectOf>
                <characteristic>
                  <code code="1" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="PRODUCT TYPE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.53"
                    displayName="PHARMACEUTICAL" xsi:type="CV">
                    <originalText>PHARMACEUTICAL</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="WHITE"
                    xsi:type="CV">
                    <originalText>white to off-white</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="2" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="COLOUR"/>
                  <value code="2" codeSystem="2.16.840.1.113883.2.20.6.24" displayName="BLUE"
                    xsi:type="CV">
                    <originalText>Blue</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="3" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SHAPE"/>
                  <value code="11" codeSystem="2.16.840.1.113883.2.20.6.25" displayName="OVAL"
                    xsi:type="CV">
                    <originalText>Oval</originalText>
                  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="4" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SIZE"/>
                  <value xsi:type="PQ" value="14" unit="mm"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="5" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="SCORE"/>
                  <value code="1" codeSystem="2.16.840.1.113883.2.20.6.4" displayName="1"
				  xsi:type="CV">
				  </value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="6" codeSystem="2.16.840.1.113883.2.20.6.23" displayName="IMPRINT"/>
                  <value xsi:type="ST">A4</value>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="8" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="COMBINATION PRODUCT"/>
                  <value code="xx" codeSystem="2.16.840.1.113883.2.20.6.8" xsi:type="CV"
                    displayName="NOT A COMBINATION PRODUCT"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="9" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="PHARMACEUTICAL STANDARD"/>
                  <value code="4" codeSystem="2.16.840.1.113883.2.20.6.5" displayName="MFR"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="10" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="SCHEDULE"/>
                  <value code="6" codeSystem="2.16.840.1.113883.2.20.6.2" displayName="PRESCRIPTION"
                    xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="96447" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="ANGIOTENSIN II RECEPTOR ANTAGONISTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <subjectOf>
                <characteristic>
                  <code code="11" codeSystem="2.16.840.1.113883.2.20.6.23"
                    displayName="THERAPEUTIC CLASS"/>
                  <value code="61287" codeSystem="2.16.840.1.113883.2.20.6.6"
                    displayName="MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS" xsi:type="CV"/>
                </characteristic>
              </subjectOf>
              <consumedIn>
                <substanceAdministration>
                  <routeCode code="20053000" codeSystem="2.16.840.1.113883.2.20.6.7" displayName="ORAL USE"/>
                </substanceAdministration>
              </consumedIn>
            </manufacturedProduct>
          </subject>
        </section>
      </component>
      <component>
        <!--Title Page section-->
        <section ID="d8d30d86-e343-48f4-9cec-524834b3803b">
          <id root="eed00b53-cdb2-4aa6-9e82-88b7d793b208"/>
          <code code="60001" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="TITLE PAGE"/>
          <title>TITLE PAGE</title>
          <effectiveTime value="20180101"/>
          <component>
            <section ID="be75cfb9-3131-4903-800b-267427388a13">
              <id root="b9db4be0-3f46-437a-bd7b-4a33010adaad"/>
              <code code="60002" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="TITLE"/>
              <title>TITLE</title>
              <text>
                <paragraph>
                  <sup>Pr</sup>Twynsta<sup>®</sup>
                  <br/> Telmisartan / Amlodipine (as Amlodipine Besylate) Tablets <br/> Tablets 40/5
                  mg, 40/10 mg, 80/5 mg, 80/10 mg <br/> Angiotensin II AT1 Receptor Blocker /
                  Calcium Channel Blocker </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="f187daf9-5e75-425a-9de6-f6ce1af2a965">
              <id root="ac26f58c-721a-4c51-8bbc-c9dddb1f1233"/>
              <code code="60003" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="COMPANY NAME AND ADDRESS"/>
              <title>COMPANY NAME AND ADDRESS</title>
              <text>
                <paragraph> Boehringer Ingelheim (Canada) Ltd. <br/> 5180 South Service Road <br/>
                  Burlington, Ontario <br/> L7L 5H4 </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="bf2dab4e-fd04-4ec9-9cdc-247188622d0f">
              <id root="a5f1dea3-d907-4664-b46f-e1d9736d47af"/>
              <code code="60004" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="DATE OF INITIAL APPROVAL"/>
              <title>DATE OF INITIAL APPROVAL</title>
              <text>
                <paragraph>December 20, 2018</paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="b0184119-8fd7-4378-af77-b227c39e8445">
              <id root="ad78301c-29a9-41af-96f8-d58815fed296"/>
              <code code="60005" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="DATE OF REVISION"/>
              <title>DATE OF REVISION</title>
              <text>
                <paragraph>December 20, 2019</paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="ebc3f3dc-71be-424f-91ef-8aca8c138b21">
              <id root="efd8c4c1-d0dd-434d-b1c2-4daa18752fa8"/>
              <code code="60006" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="CONTROL NUMBER"/>
              <title>CONTROL NUMBER</title>
              <text>
                <paragraph>125785</paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
        </section>
      </component>
      <component>
        <!-- Recent Major Changes -->
        <section ID="a7cee5c8-7ee9-4fd2-884e-7a50c06b27e1">
          <id root="dd1e1c43-f0d3-4ba8-b1f5-ad009a5dd5a8"/>
          <code code="60007" codeSystem="2.16.840.1.113883.2.20.6.60"
            displayName="RECENT MAJOR LABEL CHANGES"/>
          <title>RECENT MAJOR LABEL CHANGES</title>
          <text>
            <table ID="t6" width="100%">
              <tbody>
                <tr>
                  <td>Indications (1)</td>
                  <td>05/2018</td>
                </tr>
                <tr>
                  <td>Indications, Pediatrics (1.1)</td>
                  <td>05/2018</td>
                </tr>
                <tr>
                  <td>Contraindications (2)</td>
                  <td>04/2018</td>
                </tr>
                <tr>
                  <td>Serious Warning and Precautions Box (3), Lactic Acidosis and Severe Hepatomegaly with Steatosis [Removed]</td>
                  <td>05/2018</td>
                </tr>
                <tr>
                  <td>Dosage and Administration, Recommended Dose and Dose Adjustment (4.3)</td>
                  <td>08/2018</td>
                </tr>
                <tr>
                  <td>Warnings and Precautions, Endocrine and Metabolism (7)</td>
                  <td>05/2018</td>
                </tr>
              </tbody>
            </table>
          </text>
          <effectiveTime value="20180101"/>
        </section>
      </component>
      <component>
        <!-- Part I: Health Professional Information -->
        <section ID="c16a947e-e2be-45c0-8b2e-15d0d0eebea8">
          <id root="e6bb83b9-2602-4f96-9077-b8b9535c254e"/>
          <code code="60008" codeSystem="2.16.840.1.113883.2.20.6.60"
            displayName="PART I: HEALTH PROFESSIONAL INFORMATION"/>
          <title>PART I: HEALTH PROFESSIONAL INFORMATION</title>
          <effectiveTime value="20180101"/>
          <component>
            <section ID="a52ea4fa-2b79-4dbc-8d99-6843adc2dec8">
              <id root="9a3f869a-7734-425a-85d8-b8bd4d3500a5"/>
              <code code="60009" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="1 INDICATIONS"/>
              <title>1 INDICATIONS</title>
              <text>
                <paragraph> sample text 
				</paragraph>
              </text>
              <effectiveTime value="20180101"/>
              <component>
                <section ID="f2aa7e0e-2042-4a4c-a783-9ad4e8717a32">
                  <id root="b9d44be0-3f46-437a-bd7b-4a3e010adaad"/>
                  <code code="60010" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="1.1 PEDIATRICS"/>
                  <title>1.1 PEDIATRICS</title>
                  <text>
                    <paragraph> TWYNSTA (telmisartan/amlodipine besylate) is indicated for treatment
                      of mild to moderate essential hypertension for whom combination therapy is
                      appropriate. <br/>
                      <br/> TWYNSTA is not indicated for initial therapy (see <linkHtml href="#be75cfb9-3131-4903-800b-267727398a13">DOSAGE AND
                        ADMINISTRATION).</linkHtml><br/>
                      <br/> Patients should be titrated on individual drugs. If the fixed dose
                      combination represents the dose and dosing frequency determined by this
                      titration, the use of TWYNSTA may be more convenient in the management of
                      patients. If during maintenance therapy dosage adjustment is necessary, it is
                      advisable to use the individual drugs. <br/>
                      <br/>
                      <content styleCode="bold">Geriatrics:</content>
                      <br/> No dose adjustment is necessary for elderly patients. It should be
                      recognized, however, that greater sensitivity in some older individuals cannot
                      be ruled out. <br/>
                      <br/>
                      <content styleCode="bold">Pediatrics (&lt; 18 years of age):</content><br/>
                      TWYNSTA is not recommended for use in patients aged below 18 years due to a
                      lack of data on safety and efficacy. </paragraph>
                  </text>
                  <effectiveTime value="20180822"/>
                </section>
              </component>
              <component>
                <section ID="be75cfb9-3132-4903-800b-267427388a13">
                  <id root="b9db4be0-3f46-447a-bd7b-4a3e010adaad"/>
                  <code code="60011" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="1.2 GERIATRICS"/>
                  <title>1.2 GERIATRICS</title>
                  <text>
                    <paragraph>sample text</paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="be75cfb9-3132-4903-801b-267427388a13">
              <id root="b9db4be0-3f46-437a-bd7b-4a3e070adaad"/>
              <code code="60012" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="2 CONTRAINDICATIONS"/>
              <title>2 CONTRAINDICATIONS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="be75cfb9-3131-4903-800b-267427398a13">
              <id root="b9db4be0-3746-437a-bd7b-4a3e010adaad"/>
              <code code="60013" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="3 SERIOUS WARNINGS AND PRECAUTIONS BOX"/>
              <title>3 SERIOUS WARNINGS AND PRECAUTIONS BOX</title>
              <text>
                <table ID="t4" border="1" cellpadding="6" cellspacing="1" width="80%">
                  <caption>Serious Warnings and Precautions</caption>
                  <tbody>
                    <tr>
                      <td>
                        <content styleCode="bold">When used in pregnancy, angiotensin receptor (AT1)
                          blockers (ARB) can cause injury or even death of the developing fetus.
                          When pregnancy is detected, TWYNSTA should be discontinued as soon as
                          possible (see WARNINGS AND PRECAUTIONS, Special Populations).</content>
                      </td>
                    </tr>
                  </tbody>
                </table>
                <paragraph>
                  <content styleCode="bold">
                    <content styleCode="underline"> General </content>
                  </content><br/>A case of rare but fatal angioedema had occurred in a patient who
                  had been medicated for about 6 months with telmisartan, one of the active
                  components of TWYNSTA. The Autopsy Report described evidence of edema of the
                  laryngeal mucosa, with terminal respiratory and circulatory failure. This is in
                  the context of approximately 5.2 million patient-years exposure to telmisartan
                  annually. <br/><br/> If laryngeal stridor or angioedema of the face, extremities,
                  lips, tongue, or glottis occurs, TWYNSTA should be discontinued immediately, the
                  patient treated appropriately in accordance with accepted medical care, and
                  carefully observed until the swelling disappears. In instances where swelling is
                  confined to the face and lips, the condition generally resolves without treatment,
                  although antihistamines may be useful in relieving symptoms. Where there is
                  involvement of tongue, glottis, or larynx, likely to cause airway obstruction,
                  appropriate therapy (including, but not limited to 0.3 to 0.5 ml of subcutaneous
                  epinephrine solution 1:1000) should be administered promptly (see <linkHtml
                    href="#c2b713f2-cc40-11e9-a32f-2a2ae2dbcce4">ADVERSE REACTIONS - Post Marketing
                    Adverse Drug Reactions; Telmisartan</linkHtml>). <br/><br/> Patients with a
                  known hypersensitivity (anaphylaxis) or angioedema to ARBs should not be treated
                  with TWYNSTA (see <linkHtml href="#a63c33a5-e08a-473c-b8a2-b32dbd215f7a">ADVERSE
                    REACTIONS, Clinical Trial Adverse Drug Reactions - Unknown Frequencies, Immune
                    System Disorders, Angioedema</linkHtml> and <linkHtml href="#c2b713f2-cc40-11e9-a32f-2a2ae2dbcce4">ADVERSE REACTIONS - Post
                      Marketing Adverse Drug Reactions; Telmisartan).</linkHtml> <br/><br/>
                  <content styleCode="bold">Beta-blocker withdrawal:</content> TWYNSTA gives no
                  protection against the dangers of abrupt beta- blocker withdrawal and such
                  withdrawal should be done by the gradual reduction of the dose of beta-blocker.
                </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="be75cfb9-3131-4903-800b-267727398a13">
              <id root="b9db4be0-3f46-437a-bd7b-4a3ee10adaad"/>
              <code code="60014" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="4 DOSAGE AND ADMINISTRATION"/>
              <title>4 DOSAGE AND ADMINISTRATION</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
              <component>
                <section ID="be75cfb9-3131-4103-800b-267727398a13">
                  <id root="b9db1be0-3f46-437a-bd7b-4a3e010adaad"/>
                  <code code="60015" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="4.1 DOSING CONSIDERATIONS"/>
                  <title>4.1 DOSING CONSIDERATIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="b3d876c1-c36c-4ed5-8993-c507e3ab9f2e">
                  <id root="da2d22a3-b5c2-4a62-b138-9594dd0491bb"/>
                  <code code="60016" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="4.2 RECOMMENDED DOSE AND DOSAGE ADJUSTMENT"/>
                  <title>4.2 RECOMMENDED DOSE AND DOSAGE ADJUSTMENT</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-472c-b8a2-a12dba105f3a">
                  <id root="a473c162-e176-44d0-b797-2b7b6cf00343"/>
                  <code code="60017" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="4.3 ADMINISTRATION"/>
                  <title>4.3 ADMINISTRATION</title>
                  <text>
				  <paragraph>sample text</paragraph>				  
				  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-472c-b8a2-a12dba105f4a">
                  <id root="a473c162-e176-44d0-b797-2b7b6c100e43"/>
                  <code code="60018" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="4.4 RECONSTITUTION"/>
                  <title>4.4 RECONSTITUTION</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-472c-b8a2-a12dba105f5a">
                  <id root="a473c162-e276-44d0-b797-2b7b6cf00e43"/>
                  <code code="60019" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="4.5 MISSED DOSE"/>
                  <title>4.5 MISSED DOSE</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="a63c33a5-e08a-472c-b8a2-a12dba105f6a">
              <id root="a473c162-e176-44d0-b797-2b7b6ce00e43"/>
              <code code="60020" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="5 OVERDOSAGE"/>
              <title>5 OVERDOSAGE</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="a63c33a5-e08a-472c-b8a2-a12dba105f7a">
              <id root="a473c162-e176-44d0-b797-2b7b6cf08e43"/>
              <code code="60021" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING"/>
              <title>6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING</title>
              <text>
			  <paragraph>sample text</paragraph>
			  </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="a47ddb1b-4d6c-4f0b-97d7-7feb718963e1">
              <id root="a473c162-e176-44d0-b797-2b7b6cfa0e43"/>
              <code code="60022" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="7 WARNINGS AND PRECAUTIONS"/>
              <title>7 WARNINGS AND PRECAUTIONS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
              <component>
                <section ID="e7f348e6-c9c4-43d5-950e-2a754092a1fa">
                  <id root="a473d162-e176-44d0-b797-2b7b6cf00e43"/>
                  <code code="60023" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="7.1 SPECIAL POPULATIONS"/>
                  <title>7.1 SPECIAL POPULATIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                  <component>
                    <section ID="e94dc526-7275-40e3-8386-c43f0018b303">
                      <id root="a473c162-e176-44d0-b297-2b7b6cf00e43"/>
                      <code code="60024" codeSystem="2.16.840.1.113883.2.20.6.60"
                        displayName="7.1.1 PREGNANT WOMEN"/>
                      <title>7.1.1 PREGNANT WOMEN</title>
                      <text>
                        <paragraph> sample text </paragraph>
                      </text>
                      <effectiveTime value="20180101"/>
                    </section>
                  </component>
                  <component>
                    <section ID="a63c33a5-e08a-472c-b8a2-b12dbd115f7a">
                      <id root="a473c162-e176-44d0-b797-2b7c6cf00e43"/>
                      <code code="60025" codeSystem="2.16.840.1.113883.2.20.6.60"
                        displayName="7.1.2 BREAST-FEEDING"/>
                      <title>7.1.2 BREAST-FEEDING</title>
                      <text>
                        <paragraph> sample text </paragraph>
                      </text>
                      <effectiveTime value="20180101"/>
                    </section>
                  </component>
                  <component>
                    <section ID="db71c420-7743-43da-8386-5463a89b0f93">
                      <id root="a423c162-e176-44d0-b797-2b7b6cf00e43"/>
                      <code code="60026" codeSystem="2.16.840.1.113883.2.20.6.60"
                        displayName="7.1.3 PEDIATRICS"/>
                      <title>7.1.3 PEDIATRICS</title>
                      <text>
                        <paragraph> sample text </paragraph>
                      </text>
                      <effectiveTime value="20180101"/>
                    </section>
                  </component>
                  <component>
                    <section ID="ee781ef0-be0c-406f-95f9-1122d8bf9968">
                      <id root="a473c162-e176-44d0-b797-2b7b6c000e43"/>
                      <code code="60027" codeSystem="2.16.840.1.113883.2.20.6.60"
                        displayName="7.1.4 GERIATRICS"/>
                      <title>7.1.4 GERIATRICS</title>
                      <text>
                        <paragraph> sample text </paragraph>
                      </text>
                      <effectiveTime value="20180101"/>
                    </section>
                  </component>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="fa8186fe-cc41-11e9-a32f-2a2ae2dbcce4">
              <id root="a473c162-e176-44d0-b797-2b7b6cf00e73"/>
              <code code="60028" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="8 ADVERSE REACTIONS"/>
              <title>8 ADVERSE REACTIONS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
              <component>
                <section ID="b238395c-cc41-11e9-a32f-2a2ae2dbdce4">
                  <id root="a473c162-e176-44d0-c797-2b7b6cf00e43"/>
                  <code code="60029" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="8.1 ADVERSE REACTION OVERVIEW"/>
                  <title>8.1 ADVERSE REACTION OVERVIEW</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a98b942a-cc41-11e9-a32f-2a2ae2dbcce4">
                  <id root="a473c162-e176-4ad0-b797-2b7b6cf00e43"/>
                  <code code="60030" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="8.2 CLINICAL TRIAL ADVERSE REACTIONS"/>
                  <title>8.2 CLINICAL TRIAL ADVERSE REACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a0065926-cc41-11e9-a32f-2a2ae2dbcce4">
                  <id root="a4a3c162-e176-44d0-b797-2b7b6cf00e43"/>
                  <code code="60031" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="8.3 LESS COMMON CLINICAL TRIAL ADVERSE REACTIONS"/>
                  <title>8.3 LESS COMMON CLINICAL TRIAL ADVERSE REACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a6d30f16-cc41-11e9-a32f-2a2ae2dbcce4">
                  <id root="a463c162-e176-44d0-b797-2b7b6cf00e43"/>
                  <code code="60032" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="8.4 ABNORMAL LABORATORY FINDINGS: HEMATOLOGIC"/>
                  <title>8.4 ABNORMAL LABORATORY FINDINGS: HEMATOLOGIC</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-473c-b8a2-b32dbd215f7a">
                  <id root="a473e162-e176-44d0-b797-2b7b6cf00e43"/>
                  <code code="60033" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="8.5 CLINICAL TRIAL ADVERSE REACTIONS (PEDIATRICS)"/>
                  <title>8.5 CLINICAL TRIAL ADVERSE REACTIONS (PEDIATRICS)</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="c2b713f2-cc40-11e9-a32f-2a2ae2dbcce4">
                  <id root="a473c162-e176-44d0-b797-3b7b6cf00e43"/>
                  <code code="60034" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="8.6 POST-MARKET ADVERSE REACTIONS"/>
                  <title>8.6 POST-MARKET ADVERSE REACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="f3daf956-cc41-11e9-a32f-2a2ae2dbcce4">
              <id root="a473c162-e176-44d0-b797-2b7b6cf0d343"/>
              <code code="60035" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="9 DRUG INTERACTIONS"/>
              <title>9 DRUG INTERACTIONS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
              <component>
                <section ID="be75cfb9-3131-4903-800b-267527398a13">
                  <id root="b8db4be0-3f46-437a-bd7b-4a3e010adaad"/>
                  <code code="60036" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.1 SERIOUS DRUG INTERACTIONS BOX"/>
                  <title>9.1 SERIOUS DRUG INTERACTIONS BOX</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-473c-b8a2-b14dbd315f7a">
                  <id root="a473c162-e176-44d0-b797-2b7bfcf00e43"/>
                  <code code="60037" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.2 OVERVIEW"/>
                  <title>9.2 OVERVIEW</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-473c-b8d2-b14dbd315f7a">
                  <id root="a473c162-e176-44d0-b797-2b7b6cf00e33"/>
                  <code code="60038" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.3 DRUG-DRUG INTERACTIONS"/>
                  <title>9.3 DRUG-DRUG INTERACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e0aa-473c-b8a2-b14dbd315f7a">
                  <id root="d473c162-e176-44d0-b797-2b7b6cf00e43"/>
                  <code code="60039" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.4 DRUG-FOOD INTERACTIONS"/>
                  <title>9.4 DRUG-FOOD INTERACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e08a-47bc-b8d2-b14dbd315f7a">
                  <id root="a473c162-e176-94d0-b797-2b7b6cf00e43"/>
                  <code code="60040" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.5 DRUG-HERB INTERACTIONS"/>
                  <title>9.5 DRUG-HERB INTERACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="be78cfb9-3131-4903-800b-267527398a13">
                  <id root="b9db4be0-3f46-437a-be7b-4a3e010adaad"/>
                  <code code="60041" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.6 DRUG-LABORATORY TEST INTERACTIONS"/>
                  <title>9.6 DRUG-LABORATORY TEST INTERACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="a63c33a5-e0aa-473c-b8a2-b14dcd315f7a">
                  <id root="a473c162-e176-44d0-b797-2b7b6af00e43"/>
                  <code code="60042" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="9.7 DRUG-LIFESTYLE INTERACTIONS"/>
                  <title>9.7 DRUG-LIFESTYLE INTERACTIONS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="fa324c26-b939-4c3a-901d-516ccc314522">
              <id root="dc0d2dd9-1c53-49dc-bbd3-d6b420d064e9"/>
              <code code="60043" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="10 ACTION AND CLINICAL PHARMACOLOGY"/>
              <title>10 ACTION AND CLINICAL PHARMACOLOGY</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
              <component>
                <section ID="aa324c26-b939-4c3a-901e-516ccc314522">
                  <id root="dc0d2dd9-1c53-49dc-cad3-d6b420d064e9"/>
                  <code code="60044" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="10.1 MECHANISM OF ACTION"/>
                  <title>10.1 MECHANISM OF ACTION</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="da324c26-b939-4d3a-901e-516ccc314522">
                  <id root="dc0d2dd9-1c53-49dc-bad4-d6b420d064e9"/>
                  <code code="60045" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="10.2 PHARMACODYNAMICS"/>
                  <title>10.2 PHARMACODYNAMICS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
              <component>
                <section ID="ba324c26-b939-4d4a-901e-516ccc314522">
                  <id root="dc0d2dd9-1c53-49dc-bad3-d6b420d004e9"/>
                  <code code="60046" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="10.3 PHARMACOKINETICS"/>
                  <title>10.3 PHARMACOKINETICS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20180101"/>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="aa324d26-c939-443a-901e-526dcc314522">
              <id root="ec0d2dd9-1c53-49dc-bad3-d6b420d064e9"/>
              <code code="60047" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="11 STORAGE, STABILITY AND DISPOSAL"/>
              <title>11 STORAGE, STABILITY AND DISPOSAL</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
          <component>
            <section ID="aa325d26-c939-443a-901e-526dcc314522">
              <id root="cc0d2dd9-1c53-49dc-bad3-d6b420d064e9"/>
              <code code="60048" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="12 SPECIAL HANDLING INSTRUCTIONS"/>
              <title>12 SPECIAL HANDLING INSTRUCTIONS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20180101"/>
            </section>
          </component>
        </section>
      </component>
      <component>
        <!-- Part II: Scientific Information -->
        <section ID="b6a947eb-e2be-45c0-8b2e-15d0d0eebed8">
          <id root="d91389e0-c234-44d9-8327-91b121723a8f"/>
          <code code="60049" codeSystem="2.16.840.1.113883.2.20.6.60"
            displayName="PART II: SCIENTIFIC INFORMATION"/>
          <title>PART II: SCIENTIFIC INFORMATION</title>
          <effectiveTime value="20170101"/>
          <component>
            <section ID="c2875272-8229-4c12-919e-827854dcd76a">
              <id root="a134d52c-f9d4-4698-a082-84b29ee3d95a"/>
              <code code="60050" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="13 PHARMACEUTICAL INFORMATION"/>
              <title>13 PHARMACEUTICAL INFORMATION</title>
              <text>
                <paragraph>
                  <content styleCode="bold">Drug Substance – Telmisartan</content>
                  <br/><br/> Proper name: telmisartan<br/><br/> Chemical name:
                  [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'- dimethyl-2'- propyl[2,6'-
                  bi-1H-benzimidazol]-1'-yl)methyl] <br/><br/>Molecular formula and molecular mass:
                    C<sub>33</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>, 514.63 <br/><br/>
                  Structural formula: <br/><br/>
                  <renderMultiMedia referencedObject="m1"/>
                  <br/><br/> Physicochemical properties: <br/><br/> Description: <br/> Telmisartan
                  is a white to off-white, odorless crystalline powder. It is practically insoluble
                  in water and in the pH range of 3 to 9, sparingly soluble in strong acid (except
                  HCl) and soluble in strong base. <br/><br/> Polymorphism: <br/> Exhibits two
                  different polymorphic modifications, Form A (thermodynamically more stable) and
                  form B, and a third pseudo polymorphic form. <br/><br/> Melting Point: <br/>269 ±
                  1oC (polymorphic Form A) <br/> 183 ± 1oC (polymorphic Form B) <br/><br/>
                  <content styleCode="bold">Drug Substance – Amlodipine Besylate</content>
                  <br/><br/> Proper name: amlodipine besylate <br/><br/> 3-Ethyl 5-methyl
                  (4RS)-2[(2-aminoethoxy)methyl]-4-(2-
                  chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate benzenesulphonate
                  <br/><br/>Molecular formula and molecular mass:
                    C<sub>20</sub>H<sub>25</sub>IN<sub>2</sub>O<sub>5</sub>.C<sub>6</sub>H<sub>6</sub>O<sub>3</sub>S,
                  514.63 <br/><br/> Structural formula: <br/><br/>
                  <renderMultiMedia referencedObject="m2"/>
                  <br/><br/> Physicochemical properties: <br/><br/> Physical Form:<br/> Amlodipine
                  besylate is a white crystalline substance.<br/><br/> Polymorphism: <br/> Exhibits
                  two different polymorphic modifications, Form A (thermodynamically more stable)
                  and form B, and a third pseudo polymorphic form. <br/><br/> Solubility: <br/>
                  Amlodipine besylate is slightly soluble in water and sparingly soluble in ethanol,
                  M.P.= 203 C with decomposition. <br/> pKa = 9.02 at 23.5<sup>o</sup>C.
                </paragraph>
              </text>
              <effectiveTime value="20170101"/>
              <component>
                <observationMedia ID="m1">
                  <text>telmisartan structure</text>
                  <value xsi:type="ED" mediaType="image/jpeg">
                    <reference value="telmisartan-struct.jpg"/>
                  </value>
                </observationMedia>
              </component>
              <component>
                <observationMedia ID="m2">
                  <text>amlodipine structure</text>
                  <value xsi:type="ED" mediaType="image/jpeg">
                    <reference value="amlodipine-struct.jpg"/>
                  </value>
                </observationMedia>
              </component>
            </section>
          </component>
          <component>
            <section ID="a3287527-8229-4c12-919e-827854ddd76a">
              <id root="f134d52c-f9d4-4698-a082-84b29ee3d95a"/>
              <code code="60051" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="14 CLINICAL TRIALS"/>
              <title>14 CLINICAL TRIALS</title>
              <text>
                <paragraph> In a single 8-week multicenter, randomised, double-blind,
                  placebo-controlled, parallel group factorial study, 1461 patients with mean seated
                  diastolic blood pressure ≥95 and &lt;119 mmHg in which subjects were treated with
                  combination doses of TWYNSTA (telmisartan [T] and amlodipine [A] or its
                  monotherapy components, including T/A doses of T40+A5, T40+A10, T80+A5, and
                  T80+A10 mg), the combination treatments showed significant dose related reductions
                  in systolic and diastolic blood pressure from baseline values. Limited data was
                  available in subjects with severe hypertension.<br/><br/>
                  <content styleCode="bold">Study demographics and trial design</content><br/><br/>
                  Overall, 737 (50.4%) patients were male; 1160 (79.4%) Caucasian, 237 (16.2%)
                  black, and 64 (4.4%) Asian. The overall mean age was 53.1 years with 205 (14.0%)
                  of patients ≥65 years old. The majority of patients had a duration of hypertension
                  >5 years [&lt;1 year: 206 (14.1%), 1-5 years: 446 (30.5%), &gt;5 years: 806
                  (55.2%), missing: 3 (0.2%)] with 307 (21.0%) not being previously prescribed
                  antihypertensive medication, 531 (36.3%) previously treated with antihypertensive
                  monotherapy, and 623 (42.6%) previously treated with combination therapy of ≥2
                  antihypertensive medications. The overall mean body mass index (BMI) was 31.3
                  kg/m2 with 238 (16.3%) of patients being diabetic and 12 (0.8%) with renal
                  impairment. <br/><br/> The primary endpoint of this study was the change from
                  baseline in the in-clinic seated trough cuff diastolic blood pressure (DBP) after
                  8 weeks of treatment. <br/><br/>
                  <content styleCode="bold">Results</content><br/><br/> Treatment with each
                  combination dose of TWYNSTA resulted in significantly greater diastolic and
                  systolic blood pressure reductions and higher control rates compared to the
                  respective monotherapy components. The telmisartan/amlodipine combinations showed
                  dose-related reductions in systolic/diastolic blood pressure (SBP/DBP) across the
                  therapeutic dose range versus telmisartan monotherapy or amlodipine monotherapy: </paragraph>
                <table ID="t12842122" border="0" cellpadding="1" cellspacing="0" width="80%">
                  <caption>Table 5: Placebo-Subtracted Mean Change from Baseline in Seated
                    Systolic/Diastolic Blood Pressure (mmHg): Combination Therapy vs Monotherapy
                    Components</caption>
                  <tbody>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule" rowspan="2" valign="top"
                        >Amlodipine, mg</td>
                      <td styleCode="Toprule Rrule Lrule Botrule" colspan="3">Telmisartan, mg</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule">0</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">40</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">80</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule">0</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">—</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-12.1/-7.2</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-11.8/-7.8</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule">5</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-12.9/-7.2</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-19.3/-10.3</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-19.6/-12.0</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule">10</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-18.2/-10.9</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-22.2/-14.0</td>
                      <td styleCode="Toprule Rrule Lrule Botrule">-23.9/-13.9</td>
                    </tr>
                  </tbody>
                </table>
                <table ID="t5" border="0" width="80%" frame="void" rules="none">
                  <caption>Table 6: Effect on Seated Systolic/Diastolic Blood Pressure: Combination
                    Therapy vs Monotherapy</caption>
                  <colgroup>
                    <col span="4"/>
                  </colgroup>
                  <tfoot>
                    <tr>
                      <td colspan="4">*p&lt;0.05<br/>
                        <sup>1</sup>Mean change from baseline at Week 8 in seated systolic/diastolic
                        blood pressure</td>
                    </tr>
                  </tfoot>
                  <tbody>
                    <tr>
                      <td styleCode="Toprule Botrule Lrule Rrule">Treatment Group</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">Mean Change<sup>1</sup>
                      </td>
                      <td styleCode="Toprule Botrule Lrule Rrule">Difference from amlodipine 5
                        mg</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">Difference from amlodipine 10
                        mg</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Botrule Lrule Rrule">Twynsta 40/5 mg; n=270</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-13.6 / -9.4</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-7.4* / -3.6*</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-2.4* / -1.4*</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Botrule Lrule Rrule">Twynsta 80/5 mg; n=271</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-15.0 / -10.6</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-8.8* / -4.9*</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-3.9* / -2.7*</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Botrule Lrule Rrule">Amlodipine 5 mg; n=255</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-6.2 / -5.7</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">----</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">----</td>
                    </tr>
                    <tr>
                      <td styleCode="Toprule Lrule Rrule Botrule" align="left">Amlodipine 10 mg;
                        n=261</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">-11.1 / -8.0</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">----</td>
                      <td styleCode="Toprule Botrule Lrule Rrule">----</td>
                    </tr>
                  </tbody>
                </table>
              </text>
              <effectiveTime value="20170101"/>
              <component>
                <section ID="e3287527-8229-4c12-919e-827854ddd78a">
                  <id root="0134d52c-f9d4-4698-a082-84b29ee3d93a"/>
                  <code code="60052" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="14.1 TRIAL DESIGN AND STUDY DEMOGRAPHICS"/>
                  <title>14.1 TRIAL DESIGN AND STUDY DEMOGRAPHICS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20170101"/>
                </section>
              </component>
              <component>
                <section ID="a2875272-8229-4c12-919e-827854ddd78a">
                  <id root="0134a52c-f9d4-4698-a082-84b29ee3d95a"/>
                  <code code="60053" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="14.2 STUDY RESULTS"/>
                  <title>14.2 STUDY RESULTS</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20170101"/>
                </section>
              </component>
              <component>
                <section ID="a4287527-8229-4c12-919e-827954ddd78a">
                  <id root="c134d52c-f9d4-4698-a082-14b29ee3d95a"/>
                  <code code="60054" codeSystem="2.16.840.1.113883.2.20.6.60"
                    displayName="14.3 COMPARATIVE BIOAVAILABILITY STUDIES"/>
                  <title>14.3 COMPARATIVE BIOAVAILABILITY STUDIES</title>
                  <text>
                    <paragraph> sample text </paragraph>
                  </text>
                  <effectiveTime value="20170101"/>
                  <component>
                    <observationMedia ID="e7927268-5176-4ab0-b46e-46b6a6a26bb4">
                      <text>Chemical structure</text>
                      <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="chem.jpg"/>
                      </value>
                    </observationMedia>
                  </component>
                </section>
              </component>
            </section>
          </component>
          <component>
            <section ID="a2875272-8229-4c12-a19e-827954ddd78a">
              <id root="c134d52c-f9d4-4698-a082-84b29eeed95a"/>
              <code code="60055" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="15 MICROBIOLOGY"/>
              <title>15 MICROBIOLOGY</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="a42a7527-8229-4c12-a19e-827954ddd78a">
              <id root="d134d52c-f9d4-4698-a082-84b29ee3d95a"/>
              <code code="60056" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="16 NON-CLINICAL TOXICOLOGY"/>
              <title>16 NON-CLINICAL TOXICOLOGY</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="b8a4d498-0fc3-4e44-b4b6-550140d4de5d">
              <id root="be74b6e6-c431-4a5f-a18e-ed321a381456"/>
              <code code="60057" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="17 SUPPORTING PRODUCT MONOGRAPHS"/>
              <title>17 SUPPORTING PRODUCT MONOGRAPHS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
        </section>
      </component>
      <component>
        <!-- Part III: Patient Medication Information -->
        <section ID="baa4d498-0fc3-4e44-b4b6-550140d4de5d">
          <id root="be74b5e6-c431-4a5f-a18e-ed321b381456"/>
          <code code="60058" codeSystem="2.16.840.1.113883.2.20.6.60"
            displayName="PART III: PATIENT MEDICATION INFORMATION"/>
          <title>PART III: PATIENT MEDICATION INFORMATION</title>
          <effectiveTime value="20170101"/>
          <component>
            <section ID="baa4d498-0fc3-4e44-b4b6-550140dde5d">
              <id root="be74b6e6-c431-4a5f-a18e-ede21b381456"/>
              <code code="60059" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="BRAND NAME"/>
              <title>BRAND NAME</title>
              <text>
                <paragraph>
                  <sup>Pr</sup> Twynsta <sup>®</sup><br/>(Telmisartan/Amlodipine (as Amlodipine
                  Besylate)) Tablets<br/><br/> Read this carefully before you start taking TWYNSTA
                  and each time you get a refill. This leaflet is a summary and will not tell you
                  everything about TWYNSTA. Talk to your doctor, nurse, or pharmacist about your
                  medical condition and treatment and ask if there is any new information about
                  TWYNSTA.</paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="baa4d498-0fc3-4e44-b4b6-550140d4e5d">
              <id root="be7476e6-c431-4a5f-a18e-ed321b381456"/>
              <code code="60060" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="PROPER NAME IN FINAL DOSAGE FORMS"/>
              <title>PROPER NAME IN FINAL DOSAGE FORMS</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="baa4d498-0gc3-4e44-bcb6-550140d4de5d">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b321456"/>
              <code code="60061" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="WHAT IS THIS MEDICATION USED FOR?"/>
              <title>WHAT IS THIS MEDICATION USED FOR?</title>
              <text>
                <paragraph>TWYNSTA is used to treat high blood pressure in patients who already
                  receive telmisartan and amlodipine from separate tablets and who wish to take
                  instead the same doses in one tablet for convenience.</paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="bca4d498-0gc3-4e44-bcb6-550140d4de5d">
              <id root="be74b6e6-c431-4a5f-a18e-fd321b381456"/>
              <code code="60062" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="HOW DOES THIS MEDICATION WORK?"/>
              <title>HOW DOES THIS MEDICATION WORK?</title>
              <text>
                <paragraph> TWYNSTA contains a combination of 2 drugs, telmisartan and amlodipine: </paragraph>
                <list listType="unordered">
                  <item>Telmisartan is an angiotensin receptor blocker (ARB). You can recognize an
                    ARB because its medicinal ingredient ends in <content styleCode="bold"
                      >“-SARTAN”.</content></item>
                  <item>Amlodipine is a calcium channel blocker.</item>
                </list>
                <paragraph> These medicinal ingredients work together to lower blood pressure. This
                  medicine does not cure your disease. It helps to control it. Therefore, it is
                  important to continue taking TWYNSTA regularly even if you feel fine. </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="bca4d498-0gc3-4e44-bcb6-55013024de5d">
              <id root="be74b6e6-c431-4a1f-a18e-ed321b381456"/>
              <code code="60063" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="WHAT ARE THE INGREDIENTS IN THIS MEDICATION?"/>
              <title>WHAT ARE THE INGREDIENTS IN THIS MEDICATION?</title>
              <text>
                <paragraph> Telmisartan and amlodipine (as amlodipine besylate)<br/><br/> colloidal
                  anhydrous silica, FD&amp;C blue No 1 aluminium lake, ferric oxide black, ferric
                  oxide yellow, magnesium stearate, maize starch, meglumine, microcrystalline
                  cellulose, povidone K25, pregelatinized starch, sodium hydroxide, sorbitol.
                </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="bca4d498-0gc3-4e54-bcb6-550130d4de5d">
              <id root="be74b6e6-c431-4a5f-a18e-ed32bb381456"/>
              <code code="60064" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="THIS MEDICATION COMES IN THE FOLLOWING DOSAGE FORMS:"/>
              <title>THIS MEDICATION COMES IN THE FOLLOWING DOSAGE FORMS:</title>
              <text>
                <paragraph>Tablets: 40/5 mg, 40/10 mg, 80/5 mg, 80/10 mg.</paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="bca4c498-0gc3-4e44-bcb6-550134d4de5d">
              <id root="be74b6e6-c431-445f-a18e-ed321b381456"/>
              <code code="60065" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="DO NOT USE THIS MEDICATION IF:"/>
              <title>DO NOT USE THIS MEDICATION IF:</title>
              <text>
                <table ID="t1" border="1" cellpadding="6" cellspacing="1" width="80%">
                  <caption>Serious Warnings and Precautions - Pregnancy</caption>
                  <tbody>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule" rowspan="2" valign="top"> TWYNSTA
                        should not be used during pregnancy. If you discover that you are pregnant
                        while taking TWYNSTA, stop the medication and contact your doctor, nurse, or
                        pharmacist as soon as possible.</td>
                    </tr>
                  </tbody>
                </table>
                <list listType="unordered">
                  <item> Have experienced an allergic reaction to any drug used to lower blood
                    pressure. </item>
                  <item> Have renal artery stenosis (narrowing of the blood vessels to one or both
                    kidneys). </item>
                  <item> Have swelling of your legs. </item>
                  <item> Have raised aldosterone levels (water and salt retention in the body along
                    with imbalance of various blood minerals). </item>
                  <item> Are taking a medicine that contains aliskiren, such as Rasilez, used to
                    lower high blood pressure. The combination with TWYNSTA is not recommended. </item>
                  <item> Are taking an angiotensin-converting-enzyme inhibitor (ACEI). </item>
                  <item> Have angina, narrowing of a heart valve or blood vessel, heart or blood
                    vessel disease. </item>
                  <item> Have diabetes mellitus, liver or kidney disease. </item>
                  <item> Are dehydrated or suffer from excessive vomiting, diarrhea, or sweating. </item>
                  <item> Are on a low-salt diet. </item>
                  <item> Are taking a salt substitute that contains potassium, potassium
                    supplements, or a potassium-sparing diuretic (a specific kind of “water pill”
                    that makes your body keep potassium). </item>
                  <item> Are less than 18 years old. </item>
                </list>
                <paragraph> In case of surgery or anaesthesia, you should tell your doctor that you
                  are taking TWYNSTA.<br/><br/> If you take TWYNSTA together with a drug known as
                  betablockers (e.g. acebutolol, atenolol, metoprolol, nadolol), do not suddenly
                  stop using the beta-blocker. If your doctor advises you to discontinue use of the
                  beta-blocker, your dose should be decreased slowly, as recommended by your doctor,
                  before stopping it completely. <br/><br/>
                  <content styleCode="bold">Sorbitol:</content><br/> Sorbitol is a source of
                  fructose. TWYNSTA tablets 40/5 mg and 40/10 mg contain 168.64 mg sorbitol in each
                  tablet. <br/><br/>
                  <content styleCode="bold">Driving and using machines:</content><br/> Before you
                  perform tasks which may require special attention, wait until you know how you
                  respond to TWYNSTA. Dizziness, lightheadedness, or fainting can especially occur
                  after the first dose and when the dose is increased. </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="b6b37351-bbc9-46d9-b148-27ba3cb0a75e">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b281456"/>
              <code code="60066" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="TO HELP AVOID SIDE EFFECTS AND ENSURE PROPER USE, TALK TO YOUR HEALTHCARE PROFESSIONAL BEFORE YOU TAKE MEDICATION. TALK ABOUT ANY HEALTH CONDITIONS OR PROBLEMS YOU MAY HAVE, INCLUDING IF YOU:"/>
              <title>TO HELP AVOID SIDE EFFECTS AND ENSURE PROPER USE, TALK TO YOUR HEALTHCARE PROFESSIONAL BEFORE YOU TAKE MEDICATION. TALK ABOUT ANY HEALTH CONDITIONS OR PROBLEMS YOU MAY HAVE, INCLUDING IF YOU:</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="edac0d6f-3c91-48b5-99c0-e0f940925d37">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b181456"/>
              <code code="60067" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="OTHER WARNINGS YOU SHOULD KNOW ABOUT:"/>
              <title>OTHER WARNINGS YOU SHOULD KNOW ABOUT:</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="f040bb1e-8989-42c8-82dc-53a855e88f0f">
              <id root="be74b6e6-d431-4a5f-a18e-ed321b301456"/>
              <code code="60068" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="TELL YOUR HEALTHCARE PROFESSIONAL ABOUT ALL THE MEDICINES YOU TAKE, INCLUDING ANY DRUGS, VITAMINS, MINERALS, NATURAL SUPPLEMENTS OR ALTERNATIVE MEDICINES."/>
              <title>TELL YOUR HEALTHCARE PROFESSIONAL ABOUT ALL THE MEDICINES YOU TAKE, INCLUDING ANY DRUGS, VITAMINS, MINERALS, NATURAL SUPPLEMENTS OR ALTERNATIVE MEDICINES.</title>
              <text>
                <paragraph>Sample text</paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="bca40498-0gc3-4e44-bcb6-550134d4de5d">
              <id root="be74b6e6-c431-4a5f-a13e-ed321b301456"/>
              <code code="60069" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="THE FOLLOWING MAY INTERACT WITH THIS MEDICATION:"/>
              <title>THE FOLLOWING MAY INTERACT WITH THIS MEDICATION:</title>
              <text>
                <paragraph> As with most medicines, interactions with other drugs are possible. Tell
                  your doctor, nurse, or pharmacist about all the medicines you take, including
                  drugs prescribed by other doctors, vitamins, minerals, natural supplements, or
                  alternative medicines. <br/><br/>The following may interact with TWYNSTA: </paragraph>
                <list listType="unordered">
                  <item>Agents increasing serum potassium, such as a salt substitute that contains
                    potassium, potassium supplements, or a potassium-sparing diuretic (a specific
                    kind of “water pill”);</item>
                  <item>Blood pressure lowering drugs, including diuretics (“water</item>
                  <item>pills”), aliskiren-containing products (e.g. Rasilez), or
                    angiotensin-converting-enzyme inhibitors (ACEI);</item>
                  <item>Clarithromycin and Erythromycin, antibiotics used to treat
                    infections;</item>
                  <item>Lithium used to treat bipolar disease;</item>
                  <item>Nonsteroidal anti-inflammatory drugs (NSAIDs), used to reduce pain and
                    swelling. Examples include ASA (Aspirin), ibuprofen, naproxen, and
                    celecoxib;</item>
                  <item>Corticosteroids taken by mouth or injection;</item>
                  <item>Digoxin to treat heart conditions;</item>
                  <item>Warfarin used to prevent blood clots (blood thinner);</item>
                  <item>Anticonvulsant agents. Examples include carbamazepine, phenobarbital,
                    phenytoin, fosphenytoin, primidone;</item>
                  <item>Rifampicin, an antibiotic used to treat infections;</item>
                  <item>Medicines used to treat HIV/AIDS. An example is ritonavir;</item>
                  <item>Medicines used to treat fungal infections. Examples include ketoconazole,
                    itraconazole;</item>
                  <item>Atorvastatin and simvastatin used to lower cholesterol;</item>
                  <item>Sildenafil (Viagra);</item>
                  <item>St. John’s Wort;</item>
                  <item>Beta-blockers;</item>
                  <item>Diltiazem;</item>
                  <item>Mechanistic Target of Rapamycin (mTOR) inhibitors, such as sirolimus,
                    temsirolimus and everolimus;</item>
                  <item>Immunosuppressants, such as cyclosporine and tacrolimus.</item>
                </list>
                <paragraph> Lower than normal blood pressure may occur when TWYNSTA is given with
                  the following: </paragraph>
                <list listType="unordered">
                  <item> alcohol; </item>
                  <item> antidepressants; </item>
                  <item> barbiturates (sleeping pills); </item>
                  <item> narcotics (strong pain medications); </item>
                  <item> nitroglycerin or other nitrates. </item>
                </list>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="e23321cd-5111-4aa3-b650-74f93bcda261">
              <id root="be74b6e6-c431-4a5f-a18e-ed324b381456"/>
              <code code="60070" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="HOW TO TAKE THIS MEDICATION:"/>
              <title>HOW TO TAKE THIS MEDICATION:</title>
              <text>
                <paragraph> Take TWYNSTA exactly as prescribed. It is recommended to swallow your
                  dose whole with water at about the same time everyday, preferably in the
                  morning.<br/><br/> Take TWYNSTA with or without food, but it should be taken the
                  same way each day.<br/><br/> Remove your TWYNSTA tablet from the blister just
                  prior to intake. </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="cd0892a2-0e32-4fb7-9cc9-1bbfff60dee7">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b371456"/>
              <code code="60071" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="USUAL DOSE:"/>
              <title>USUAL DOSE:</title>
              <text>
                <paragraph> The usual dose of TWYNSTA is one tablet once a day. <br/><br/> If your
                  liver is not working properly, the usual dose should not exceed 40/5 mg or 40/10
                  mg once daily. </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="beaaa5b8-6693-4d4c-a897-fa5c9562b1be">
              <id root="be74b6e6-c431-4aaf-a18e-ed321b381456"/>
              <code code="60072" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="OVERDOSE:"/>
              <title>OVERDOSE:</title>
              <text>
                <table ID="t2" border="1" cellpadding="6" cellspacing="1" width="80%">
                  <caption>Overdose</caption>
                  <tbody>
                    <tr>
                      <td styleCode="Toprule Rrule Lrule Botrule" rowspan="2" valign="top"> If you
                        think you have taken too much TWYNSTA contact your doctor, nurse,
                        pharmacist, hospital emergency department or regional Poison Control Centre
                        immediately, even if there are no symptoms.</td>
                    </tr>
                  </tbody>
                </table>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="ffd59b8d-fe66-4d86-a54f-0613d4168199">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b3b1456"/>
              <code code="60073" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="MISSED DOSE:"/>
              <title>MISSED DOSE:</title>
              <text>
                <paragraph> If you have forgotten to take your dose during the day, carry on with
                  the next one at the usual time. Do not double dose. </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="cb61f530-b95a-4047-b8ea-861c5a7a05e8">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b301456"/>
              <code code="60074" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="WHAT ARE POSSIBLE SIDE EFFECTS FROM USING THIS MEDICATION?"/>
              <title>WHAT ARE POSSIBLE SIDE EFFECTS FROM USING THIS MEDICATION?</title>
              <text>
                <paragraph> Side effects may include: </paragraph>
                <list listType="unordered">
                  <item>dizziness, vertigo (feeling of spinning);</item>
                  <item>drowsiness, insomnia, fatigue;</item>
                  <item>urge to urinate during the night;</item>
                  <item>rash, eczema, redness of skin, skin eruptions, itching, hives (urticaria),
                    scaling of the skin (dermatitis exfoliative), increased sweating, drug rash,
                    hair loss, skin discolouration, photosensitivity reaction;</item>
                  <item>toxic epidermal necrolysis;</item>
                  <item>diarrhea, vomiting, constipation, nausea, upset stomach, abdominal pain,
                    flatulence, change of bowel habit;</item>
                  <item>taste abnormalities, enlarged gums;</item>
                  <item>dry mouth;</item>
                  <item>headache, migraine, anxiety, mood altered, ringing in the ears;</item>
                  <item>sleepiness, sleeplessness, tiredness;</item>
                  <item>back or leg pain, muscle cramps, joint pain, muscle spasms, joint swelling,
                    hypertonia;</item>
                  <item>visual impairment, double vision (diplopia);</item>
                  <item>upper respiratory tract infections (e.g. sore throat, inflamed sinuses,
                    common cold), flu-like illness, cough, sneezing, runny nose, shortness of
                    breath;</item>
                  <item>inability to obtain an erection;</item>
                  <item>enlarging of male breasts;</item>
                  <item>weight increased, weight decreased.</item>
                </list>
                <paragraph> If any of these affects you severely, tell your doctor, nurse or pharmacist.<br/><br/>
                  <content styleCode="bold">TWYNSTA can cause abnormal blood test results. Your
                    doctor will decide when to perform blood tests and will interpret the
                    results.</content>
                </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="ee37dfa5-6d8c-4490-b4a5-c6f2d73aa041">
              <id root="be74b6e6-c431-4a5f-a18e-eda21b381456"/>
              <code code="60075" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM"/>
              <title>SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM</title>
              <text>
                <paragraph> sample text </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="c9d75711-2ce9-451e-aa51-91026ec1555e">
              <id root="be74b6e6-c431-4a5f-a18e-ed321ba81456"/>
              <code code="60076" codeSystem="2.16.840.1.113883.2.20.6.60" displayName="STORAGE:"/>
              <title>STORAGE:</title>
              <text>
                <paragraph>Keep out of reach and sight of children. <br/><br/> Do not use TWYNSTA
                  after the expiry date which is stated on the carton. The expiry date refers to the
                  last day of that month. <br/><br/> Store in the original package in order to
                  protect from moisture and light. <br/><br/> Store at 15 - 30°C.
                  <br/><br/>Medicines should not be disposed of via wastewater or household waste.
                  Ask your pharmacist how to dispose of medicines no longer required. These measures
                  will help to protect the environment. </paragraph>
                <table ID="t3" border="1" cellpadding="6" cellspacing="1" width="80%">
                  <tbody>
                    <tr>
                      <td>
                        <content styleCode="bold">Reporting Side Effects</content>
                        <br/><br/> You can report any suspected side effects associated with the use
                        of health products to Health Canada by: <list listType="unordered">
                          <item>Visiting the Web page on Adverse Reaction Reporting
                            (https://www.canada.ca/en/health-canada/services/drugs-
                            health-products/medeffect-canada.html) for information on how to report
                            online, by mail or by fax; or </item>
                          <item> Calling toll-free at 1-866-234-2345. </item>
                        </list>
                        <content styleCode="italics">NOTE: Contact your health professional if you
                          need information about how to manage your side effects. The Canada
                          Vigilance Program does not provide medical advice. </content></td>
                    </tr>
                  </tbody>
                </table>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
          <component>
            <section ID="f6693e7a-21c9-492f-833b-4e8f3911d3a5">
              <id root="be74b6e6-c431-4a5f-a18e-ed321b380456"/>
              <code code="60077" codeSystem="2.16.840.1.113883.2.20.6.60"
                displayName="IF YOU WANT MORE INFORMATION ABOUT THIS MEDICATION:"/>
              <title>IF YOU WANT MORE INFORMATION ABOUT THIS MEDICATION:</title>
              <text>
                <paragraph>
                  <content styleCode="bold">If you want more information about TWYNSTA:</content>
                </paragraph>
                <list listType="unordered">
                  <item> Talk to your healthcare professional. </item>
                  <item> Find the full product monograph that is prepared for healthcare
                    professionals and includes this Consumer Information by visiting the Health
                    Canada website (https://www.canada.ca/en/health-canada/services/drugs-
                    health-products/drug-products/drug-product-database.html), the manufacturer’s
                    website (https://www.boehringer- ingelheim.ca), or by calling the manufacturer,
                    Boehringer Ingelheim (Canada) Ltd., at: 1-800-263-5103, ext. 84633. </item>
                </list>
                <paragraph> This leaflet was prepared by Boehringer Ingelheim (Canada) Ltd. The
                  information in this leaflet is current up to the time of the last revision date
                  shown below, but more current information may be available from the
                  manufacturer.<br/><br/> Last revised: August 7, 2019 </paragraph>
              </text>
              <effectiveTime value="20170101"/>
            </section>
          </component>
        </section>
      </component>
    </structuredBody>
  </component>
</document>
